NO20031159L - Melkesyrebakterier som er i stand til å redusere et individs tendens til åutvikle allergiske reaksjoner - Google Patents
Melkesyrebakterier som er i stand til å redusere et individs tendens til åutvikle allergiske reaksjonerInfo
- Publication number
- NO20031159L NO20031159L NO20031159A NO20031159A NO20031159L NO 20031159 L NO20031159 L NO 20031159L NO 20031159 A NO20031159 A NO 20031159A NO 20031159 A NO20031159 A NO 20031159A NO 20031159 L NO20031159 L NO 20031159L
- Authority
- NO
- Norway
- Prior art keywords
- tendency
- individual
- reducing
- lactic acid
- acid bacteria
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1236—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using Leuconostoc, Pediococcus or Streptococcus sp. other than Streptococcus Thermophilus; Artificial sour buttermilk in general
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C2220/00—Biochemical treatment
- A23C2220/20—Treatment with microorganisms
- A23C2220/202—Genetic engineering of microorganisms used in dairy technology
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/151—Johnsonii
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/231—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Dairy Products (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00120867 | 2000-09-25 | ||
| PCT/EP2001/010956 WO2002024883A2 (en) | 2000-09-25 | 2001-09-21 | Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20031159D0 NO20031159D0 (no) | 2003-03-13 |
| NO20031159L true NO20031159L (no) | 2003-05-20 |
Family
ID=8169939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20031159A NO20031159L (no) | 2000-09-25 | 2003-03-13 | Melkesyrebakterier som er i stand til å redusere et individs tendens til åutvikle allergiske reaksjoner |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7498162B2 (no) |
| EP (1) | EP1379635A2 (no) |
| JP (1) | JP2004514424A (no) |
| KR (1) | KR20030034178A (no) |
| CN (1) | CN1246456C (no) |
| AR (1) | AR033574A1 (no) |
| AU (2) | AU2056102A (no) |
| BG (1) | BG107657A (no) |
| BR (1) | BR0114105A (no) |
| CA (1) | CA2420160A1 (no) |
| CZ (1) | CZ2003749A3 (no) |
| HU (1) | HUP0302585A3 (no) |
| IL (1) | IL154284A0 (no) |
| MX (1) | MXPA03001673A (no) |
| NO (1) | NO20031159L (no) |
| NZ (1) | NZ524527A (no) |
| PL (1) | PL365246A1 (no) |
| RU (1) | RU2294366C2 (no) |
| SK (1) | SK3642003A3 (no) |
| WO (1) | WO2002024883A2 (no) |
| ZA (1) | ZA200301244B (no) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1239032A1 (en) * | 2001-03-02 | 2002-09-11 | Société des Produits Nestlé S.A. | Lactic acid bacteria as agents for treating and preventing allergy |
| EP1319410A1 (en) * | 2001-12-11 | 2003-06-18 | Société des Produits Nestlé S.A. | Use of micro-organisms for a directed delivery of substances to specific parts of the gut |
| AU2003236156A1 (en) * | 2003-04-24 | 2005-01-04 | Shin-Jen Shiao | Pharmaceutical compositions used for immune disease treatment and improvement |
| US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
| JP2008523116A (ja) * | 2004-12-14 | 2008-07-03 | アルカベロ アクチェセルスカプ | 異種タンパク質化合物をディスプレイするバクテリア細胞を含んでなる医薬組成物 |
| WO2006097949A1 (en) * | 2005-03-16 | 2006-09-21 | Actial Farmacêutica, Lda. | Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough |
| AU2006253007B2 (en) | 2005-05-31 | 2012-12-20 | Alimentary Health Ltd | Feline probiotic Bifidobacteria |
| EP2261323A1 (en) | 2005-05-31 | 2010-12-15 | The Iams Company | Feline probiotic lactobacilli |
| EP2003989A1 (en) * | 2006-03-31 | 2008-12-24 | DSMIP Assets B.V. | Process for the hydrolysis of milk proteins |
| RU2436581C2 (ru) | 2007-02-01 | 2011-12-20 | Дзе Иамс Компани | Способ уменьшения воспаления и снижения стресса у млекопитающего |
| US9771199B2 (en) * | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
| US9232813B2 (en) * | 2008-07-07 | 2016-01-12 | The Iams Company | Probiotic supplement, process for making, and packaging |
| BRPI1007274A2 (pt) * | 2009-01-27 | 2015-08-25 | Arla Foods Amba | Leite e produtos relacionados a leite de longo prazo de validade e um processo e instalação de processamento de leite para sua fabricação. |
| US10576110B2 (en) * | 2009-05-11 | 2020-03-03 | Societe Des Produits Nestle S.A. | Lactobacillus johnsonii La1 NCC533 (CNCM I-1225) and immune disorders |
| US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
| EP3338565A1 (en) * | 2010-06-04 | 2018-06-27 | N.V. Nutricia | Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins |
| CN106918709B (zh) * | 2011-09-02 | 2020-03-10 | Dh科技发展私人贸易有限公司 | 检测过敏原的系统和方法 |
| WO2013083140A1 (en) | 2011-12-07 | 2013-06-13 | N.V. Nutricia | Beta-lactoglobulin peptides for treating cow's milk protein allergy |
| WO2016148562A1 (en) * | 2015-03-18 | 2016-09-22 | N.V. Nutricia | Method for inducing oral tolerance via administration of beta-lactoglobulin derived peptide in combination with probiotic |
| CN105362296A (zh) * | 2015-11-27 | 2016-03-02 | 成都吉氧屋科技有限公司 | 乳酸菌洗鼻液 |
| WO2019212330A1 (en) * | 2018-04-30 | 2019-11-07 | N.V. Nutricia | Formula with a specific beta-lactoglobulin peptide |
| WO2019212329A1 (en) * | 2018-04-30 | 2019-11-07 | N.V. Nutricia | Formula with specific beta-lactoglobulin peptides |
| CA3140615A1 (en) * | 2019-05-16 | 2020-11-19 | Trillitye PAULLIN | Method, system and apparatus for substance identification |
| CN114149486B (zh) * | 2021-05-28 | 2023-05-12 | 中国科学院大连化学物理研究所 | 一种抗菌肽mamp-01及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9302855D0 (sv) * | 1993-09-06 | 1993-09-06 | Martin Lindberg | Method and means for producing plasmaproteinase inhibitor binding proteins |
| US5817308A (en) * | 1994-02-14 | 1998-10-06 | University Of Rochester | Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance |
| WO1996032486A1 (en) * | 1995-04-11 | 1996-10-17 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Method for the construction of vectors for lactic acid bacteria like lactobacillus such that the bacteria can efficiently express, secrete and display proteins at the surface |
| FI104465B (fi) | 1995-06-14 | 2000-02-15 | Valio Oy | Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö |
| GB9518323D0 (en) | 1995-09-07 | 1995-11-08 | Steidler Lothar | Materials and methods relating to the attachment and display of substances on cell surfaces |
| RU2170023C2 (ru) * | 1997-12-25 | 2001-07-10 | Петров Леонид Николаевич | Штамм lactobacillus acidophilus а-91, используемый для приготовления кисломолочных продуктов, штамм lactobacillus acidophilus h-91, используемый для приготовления кисломолочных продуктов, закваска для приготовления кисломолочных продуктов и препарат, способствующий адаптации организма к неблагоприятным внешним воздействиям |
| US6100388A (en) * | 1998-03-16 | 2000-08-08 | Biogaia Biologies Ab | Lactobacilli harboring aggregation gene as a vaccine delivery vehicle |
| MY129566A (en) * | 1999-01-19 | 2007-04-30 | Nestle Sa | A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance |
-
2001
- 2001-09-21 IL IL15428401A patent/IL154284A0/xx unknown
- 2001-09-21 CN CNB018162436A patent/CN1246456C/zh not_active Expired - Fee Related
- 2001-09-21 AU AU2056102A patent/AU2056102A/xx active Pending
- 2001-09-21 PL PL01365246A patent/PL365246A1/xx not_active Application Discontinuation
- 2001-09-21 US US10/362,249 patent/US7498162B2/en not_active Expired - Fee Related
- 2001-09-21 SK SK364-2003A patent/SK3642003A3/sk not_active Application Discontinuation
- 2001-09-21 EP EP01985270A patent/EP1379635A2/en not_active Withdrawn
- 2001-09-21 MX MXPA03001673A patent/MXPA03001673A/es not_active Application Discontinuation
- 2001-09-21 HU HU0302585A patent/HUP0302585A3/hu unknown
- 2001-09-21 BR BR0114105-8A patent/BR0114105A/pt not_active IP Right Cessation
- 2001-09-21 RU RU2003112013/13A patent/RU2294366C2/ru not_active IP Right Cessation
- 2001-09-21 CZ CZ2003749A patent/CZ2003749A3/cs unknown
- 2001-09-21 NZ NZ524527A patent/NZ524527A/en unknown
- 2001-09-21 CA CA002420160A patent/CA2420160A1/en not_active Abandoned
- 2001-09-21 WO PCT/EP2001/010956 patent/WO2002024883A2/en not_active Ceased
- 2001-09-21 AU AU2002220561A patent/AU2002220561B2/en not_active Ceased
- 2001-09-21 KR KR10-2003-7003576A patent/KR20030034178A/ko not_active Withdrawn
- 2001-09-21 JP JP2002529478A patent/JP2004514424A/ja not_active Withdrawn
- 2001-09-24 AR ARP010104483A patent/AR033574A1/es not_active Application Discontinuation
-
2003
- 2003-02-14 ZA ZA200301244A patent/ZA200301244B/en unknown
- 2003-03-13 NO NO20031159A patent/NO20031159L/no unknown
- 2003-03-21 BG BG107657A patent/BG107657A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US7498162B2 (en) | 2009-03-03 |
| IL154284A0 (en) | 2003-09-17 |
| CN1479788A (zh) | 2004-03-03 |
| ZA200301244B (en) | 2004-05-14 |
| SK3642003A3 (en) | 2003-08-05 |
| BR0114105A (pt) | 2003-07-29 |
| CN1246456C (zh) | 2006-03-22 |
| US20040071714A1 (en) | 2004-04-15 |
| PL365246A1 (en) | 2004-12-27 |
| EP1379635A2 (en) | 2004-01-14 |
| NZ524527A (en) | 2005-05-27 |
| RU2294366C2 (ru) | 2007-02-27 |
| CZ2003749A3 (cs) | 2003-06-18 |
| KR20030034178A (ko) | 2003-05-01 |
| AU2002220561B2 (en) | 2007-01-11 |
| NO20031159D0 (no) | 2003-03-13 |
| AR033574A1 (es) | 2003-12-26 |
| CA2420160A1 (en) | 2002-03-28 |
| JP2004514424A (ja) | 2004-05-20 |
| BG107657A (bg) | 2003-12-31 |
| HUP0302585A2 (hu) | 2003-10-28 |
| AU2056102A (en) | 2002-04-02 |
| WO2002024883A2 (en) | 2002-03-28 |
| HUP0302585A3 (en) | 2007-05-02 |
| WO2002024883A3 (en) | 2003-11-06 |
| MXPA03001673A (es) | 2003-06-09 |
| AU2002220561C1 (en) | 2002-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20031159L (no) | Melkesyrebakterier som er i stand til å redusere et individs tendens til åutvikle allergiske reaksjoner | |
| EE05450B1 (et) | 4-jodofenlaminobenshdroksaamhapete oksgeenitud estrid, nende kristallvormid ja farmatseutilised kompositsioonid ning kasutamine | |
| NO20013770D0 (no) | Metoder og blandinger for å öke antall hvite blodceller | |
| EE05157B1 (et) | N-[(asendatud bensüül)-4-piperidinüüli v?i pürrolidinüül]aminohüdroksüalkoksüfenüülide derivaadid, meetod nende valmistamiseks ning nende kasutamine meditsiinis | |
| ID24734A (id) | Bakteri asam laktat yang meningkatkan kekebalan | |
| BR0316350A (pt) | Diaminotriazóis úteis como inibidores de proteìna cinases | |
| EP1496896A4 (en) | AKT INHIBITORS EFFECT | |
| EP1496906A4 (en) | HEMMER OF ACT ACTIVITY | |
| ATE361084T1 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
| DE60024988D1 (de) | Herstellung von therapeutischem mikroschaum | |
| NO20032388D0 (no) | Salter av et isotiazol-4-karboksamid og anvendelse derav som anti-hyperproliferasjonsmidler | |
| AU2002216113A1 (en) | Skin cleansing bar with high levels of liquid emollient | |
| PT1551952T (pt) | Seleção e utilização de bactérias do ácido láctico para reduzir a inflamação provocada por helicobacter | |
| NO20040389L (no) | Nye vinylkarboksylsyrederivater og deres anvendelse som antidiabetika | |
| BR0307071A (pt) | ésteres hidroxamato do ácido n-(fenil 4-substituìdo)-antranìlico | |
| EP1584320A4 (en) | COSMETIC COMPOSITION WITH GLYCERYLAMINO-ACID DERIVATIVES | |
| AU2002213422A1 (en) | Synthesis of 2-hydroxymethylglutamic acid and congeners thereof | |
| BR0304298A (pt) | Composição contendo um ácido orgânico cosmeticamente ativo e um produto de legume | |
| DE602004022034D1 (de) | Herstellung von konjugierten linolsäuren und linolsäuresalzen | |
| NO20022007D0 (no) | Krystaller av et oksyiminoalkansyrederivater og deres anvendelse som antidiabetika | |
| DK1666473T3 (da) | Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens | |
| EP1301203A4 (en) | VACCINE CONTAINING AZYL-GLYCERYL PHOSPHATIDYLINOSITOL MANNO-OLIGOSACCHARIDE AS AN ACTIVE SUBSTANCE | |
| BRPI0417692A (pt) | uso de uma composição, método de redução dos efeitos do estresse mediado psicologicamente na pele de um ser humano ou animal, composição, suplemento nutritivo, composição cosmética, e, método para identificar um composto capaz de reduzir os efeitos e método de produção de uma composição para a redução dos efeitos, do estresse mediado psicologicamente sobre a pele de um ser humano ou animal | |
| DE69828522D1 (de) | Antithrombotische mittel | |
| NO20003799D0 (no) | Innkorporering av kolesterol-senkende midler i konfektdosisformer |